Filed Pursuant to Rule 424(b)(5)
Registration No. 333-257114
The information in this preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended, but is not complete and may be changed. buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion, Dated August 17, 2021
PROSPECTUS SUPPLEMENT
(To prospectus dated June 15, 2021)
Shares
PennyMac Mortgage Investment Trust
% Series C Cumulative Redeemable Preferred Shares of Beneficial Interest
(Liquidation Preference $25.00 Per Share)
We are offering to the public of our % Series C Cumulative Redeemable Preferred Shares of Beneficial Interest, $0.01 par value per share, which we refer to in this prospectus supplement as the Series C Preferred Shares. This is an original issuance of the Series C Preferred Shares. Holders of Series C Preferred Shares will be entitled to receive cumulative cash dividends at a rate of % per annum of the $25.00 per share liquidation preference (equivalent to $ per annum per share). Dividends will be payable quarterly in arrears on the 15th day of each March, June, September and December, commencing on December 15, 2021 (provided that if any dividend payment date is not a business day, then the dividend which would otherwise have been payable on that dividend payment date may be paid on the next succeeding business day). Dividends will accumulate and be cumulative from, and including, the date of original issuance, which is expected to be August , 2021.
The Series C Preferred Shares will not be redeemable before , 2026, except in connection with maintaining our qualification as a real estate investment trust, or REIT, for U.S. federal income tax purposes and except as described below upon the occurrence of a Change of Control (as defined herein). On or after , 2026, we may, at our option, redeem any or all of the Series C Preferred Shares at $25.00 per share plus any accumulated and unpaid dividends thereon to, but not including, the redemption date. In addition, upon the occurrence of a Change of Control, we may, at our option, redeem any or all of the Series C Preferred Shares within 120 days after the first date on which such Change of Control occurred at $25.00 per share plus any accumulated and unpaid dividends thereon to, but not including, the redemption date. The Series C Preferred Shares have no stated maturity, are not subject to any sinking fund or mandatory redemption and will remain outstanding indefinitely unless redeemed or repurchased by us or converted into our common shares of beneficial interest, $0.01 par value per share, or common shares, in connection with a Change of Control by the holders of Series C Preferred Shares.
Upon the occurrence of a Change of Control, each holder of Series C Preferred Shares will have the right (subject to our election to redeem the Series C Preferred Shares in whole or in part, as described above, prior to the Change of Control Conversion Date (as defined herein)) to convert some or all of the Series C Preferred Shares held by such holder on the Change of Control Conversion Date into a number of our common shares per Series C Preferred Share equal to the lesser of:
| • | | the quotient obtained by dividing (i) the sum of the $25.00 liquidation preference per Series C Preferred Share plus the amount of any accumulated and unpaid dividends thereon to, but not including, the Change of Control Conversion Date (unless the Change of Control Conversion Date is after a dividend record date (as defined herein) and prior to the corresponding dividend payment date for the Series C Preferred Shares, in which case no additional amount for such accumulated and unpaid dividends will be included in this sum), by (ii) the Common Share Price (as defined herein); and |
| • | | , or the Share Cap, subject to certain adjustments as explained herein; |
in each case, on the terms and subject to the conditions described in this prospectus supplement, including provisions for the receipt, under specified circumstances, of alternative consideration as described in this prospectus supplement.
No current market exists for the Series C Preferred Shares. We intend to apply to list the Series C Preferred Shares on the New York Stock Exchange, or the NYSE, under the symbol “PMT PrC.” If listing is approved, we expect trading on the NYSE to commence within 30 days after the initial issuance of the Series C Preferred Shares. Our common shares are listed on the NYSE under the trading symbol “PMT.”
There are certain restrictions on the ownership and transfer of the Series C Preferred Shares intended to maintain our qualification as a REIT. Please see the sections entitled “Description of the Series C Preferred Shares—Restrictions on Ownership and Transfer” in this prospectus supplement and “Description of Shares of Beneficial Interest—Restrictions on Ownership and Transfer” in the accompanying prospectus. In addition, except under limited circumstances as described in this prospectus supplement, holders of the Series C Preferred Shares generally will not have any voting rights.
Investing in the Series C Preferred Shares involves a high degree of risk. See “Risk Factors” beginning on page S-8 of this prospectus supplement and in the reports we file with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, incorporated by reference into this prospectus supplement and the accompanying prospectus, to read about factors you should consider before making an investment in the Series C Preferred Shares.
| | | | | | | | |
| |
| | Per Share | | | Total(1) | |
Price to the public(2) | | $ | | | | $ | | |
Underwriting discounts and commissions | | $ | | | | $ | | |
Proceeds to us (before expenses) | | $ | | | | $ | | |
| |
(1) | Assumes no exercise of the underwriters’ over-allotment option. |
(2) | Plus accrued dividends, if any, from August , 2021 if settlement occurs after that date. |
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The underwriters have an option to purchase a maximum of additional Series C Preferred Shares solely to cover over-allotments, if any, on the same terms and conditions set forth above within 30 days of the date of this prospectus supplement.
Delivery of the Series C Preferred Shares will be made on or about August , 2021, in book-entry form only through The Depository Trust Company, or DTC.
| | | | | | | | | | | | |
Joint Book-Running Managers |
| | | | |
Morgan Stanley | | | | BofA Securities | | | | Goldman Sachs & Co. LLC |
| | | | | | |
Keefe, Bruyette & Woods, Inc | | | | RBC Capital Markets | | | | UBS Investment Bank | | | | Wells Fargo Securities |
A Stifel Company | | | | | | | | | | | | |
The date of this prospectus supplement is August , 2021.